News
ReNeuron's latest press releases
Notification of Investor Evening on 27th July 2010. 15/07/10
ReNeuron Group plc (AIM: RENE) (the ‘Company’), a leading, UK-based stem cell business, is pleased to announce that it will host an …
ReNeuron presents new data showing how its stem cells work to repair brain damage. 12/07/10
Guildford, UK, 12 July 2010: ReNeuron Group plc (LSE: RENE.L) today announces important new data regarding the mechanisms of action of its lead CTX …
Preliminary Results for the year ending 31 March 2010 . 29/06/10
Reneuron announces preliminary results for the year ending 31 March 2010.
Preliminary results notification. 17/06/10
ReNeuron Group plc (AIM: RENE.L), a leading UK-based stem cell company, today announces that it will report its preliminary results for the 12 months …
New positive data regarding ReNeuron's stem cell line for stroke to be presented at US conference. 29/04/10
Guildford, UK, 29 April 2010: ReNeuron Group plc (LSE: RENE.L) today announces that positive data from a number of new pre-clinical studies using its …
ReNeuron cited as a regenerative medicine leader in UK Government's . 22/03/10
Guildford, UK, 22 March 2010: ReNeuron Group plc (LSE: RENE.L) is pleased to learn that it has been cited as a UK-based world leader in regenerative …
ReNeuron signs further stem cell manufacturing contracts with Angel Biotechnology for stroke clinical trial. 18/03/10
Guildford, UK, 18 March 2010: ReNeuron Group plc (LSE: RENE.L) today announces that it has signed two further clinical-grade stem cell manufacturing …
Second closing of the Placing.. 15/03/10
Guildford, UK, 15 March 2010: ReNeuron Group plc (LSE: RENE.L) announced on 22 February 2010 that it had raised approximately £4.7 million, …
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
